Zopa Retreatment and Vector Shedding in Adults With RRP

NCT06538480 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent Respiratory Papillomatosis
Papillomavirus Infection
Papillomaviridae

Interventions

DRUG: Zopapogene imadenovec (Zopa)

Sponsor

Precigen, Inc